title: Safety and efficacy of recombinant activated factor VII for long-term secondary prophylaxis in a haemophilia boy with high-titre inhibitors.
authors.forename: A
authors.initials: A
authors.lastname: Chuansumrit
authors.forename: N
authors.initials: N
authors.lastname: Sirachainan
authors.forename: M
authors.initials: M
authors.lastname: Panuwannakorn
authors.forename: P
authors.initials: P
authors.lastname: Wongwerawattanakoon
authors.forename: P
authors.initials: P
authors.lastname: Kadegasem
authors.forename: W
authors.initials: W
authors.lastname: Choeyprasert
authors.forename: W
authors.initials: W
authors.lastname: Sasanakul
mesh_terms: D000293:Adolescent; D019774:Blood Coagulation Factor Inhibitors / Q000097:blood*; D005091:Exons; D005169:Factor VIII / Q000037:antagonists & inhibitors* / Q000235:genetics / Q000276:immunology; D015942:Factor VIIa / Q000627:therapeutic use*; D017353:Gene Deletion; D006467:Hemophilia A / Q000188:drug therapy*; D006801:Humans; D007108:Immune Tolerance; D008297:Male
chemical_list: D019774:Blood Coagulation Factor Inhibitors; D005169:Factor VIII; D015942:Factor VIIa